Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO), has officially commercialized its...
Day: February 4, 2026
In a milestone that has eluded HIV researchers for over four decades, scientists at The Wistar Institute...
Novo Nordisk has announced headline results from the REIMAGINE-2 Phase 3 trial, positioning its investigational once-weekly therapy,...
As the international community observes World Neglected Tropical Diseases (NTD) Day 2026, a dual narrative of triumph...
